{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:48:09Z","timestamp":1761058089736,"version":"build-2065373602"},"reference-count":114,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":3478,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.bbmt.2005.07.001","type":"journal-article","created":{"date-parts":[[2005,9,22]],"date-time":"2005-09-22T07:21:28Z","timestamp":1127373688000},"page":"739-754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Chemotherapy and Hematopoietic Stem Cell Transplantation for Adult T-Cell Lymphoblastic Lymphoma: Current Status and Controversies"],"prefix":"10.1016","volume":"11","author":[{"given":"Mahmoud","family":"Aljurf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Z.A.","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2005.07.001_bib1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1200\/JCO.1995.13.2.359","article-title":"Non-Hodgkin\u2019s lymphomas of childhood and adolescence","volume":"13","author":"Reiter","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib2","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"The Non-Hodgkin\u2019s Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphomas","volume":"89","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.07.001_bib3","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/beha.2002.0230","article-title":"Treatment of lymphoblastic lymphoma in adults","volume":"15","author":"Hoelzer","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.7326\/0003-4819-89-3-319","article-title":"Convoluted lymphocytic lymphoma in adults","volume":"89","author":"Rosen","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2005.07.001_bib5","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1002\/1097-0142(19811201)48:11<2347::AID-CNCR2820481102>3.0.CO;2-X","article-title":"Lymphoblastic lymphoma","volume":"48","author":"Nathwani","year":"1978","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2005.07.001_bib6","first-page":"1161","article-title":"Management of childhood non-Hodgkin\u2019s lymphoma","volume":"61","author":"Murphy","year":"1977","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.bbmt.2005.07.001_bib7","first-page":"75","article-title":"Leukosarkomatose and myelobastenleukaamie","volume":"61","author":"Sternberg","year":"1916","journal-title":"Beitr Pathol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib8","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/archpedi.1932.01950130003001","article-title":"Mediastinal tumor in acute leukemia","volume":"44","author":"Cooke","year":"1932","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.bbmt.2005.07.001_bib9","series-title":"Atlas of Tumor Pathology. Section 3, Fascicle 8","article-title":"Tumors of the hematopoietic-lymphoid system","author":"Rappaport","year":"1966"},{"key":"10.1016\/j.bbmt.2005.07.001_bib10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(73)90469-8","article-title":"Characterisation of malignant mediastinal lymphoid neoplasm (Sternberg sarcoma) as thymic in origin","volume":"1","author":"Smith","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2005.07.001_bib11","series-title":"Conflicts in Childhood Cancer","first-page":"147","article-title":"Malignant lymphoma of the convoluted lymphocytes","author":"Barcos","year":"1975"},{"key":"10.1016\/j.bbmt.2005.07.001_bib12","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/1097-0142(197410)34:8+<1488::AID-CNCR2820340822>3.0.CO;2-C","article-title":"Immunologic characterization of human malignant lymphomas","volume":"34","author":"Lukes","year":"1974","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2005.07.001_bib13","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/1097-0142(197608)38:2<964::AID-CNCR2820380248>3.0.CO;2-V","article-title":"Malignant lymphoma, lymphoblastic","volume":"38","author":"Nathwani","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2005.07.001_bib14","first-page":"2112","article-title":"The non-Hodgkin\u2019s lymphoma pathological classification project","volume":"49","author":"Rosenberg","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2005.07.001_bib15","doi-asserted-by":"crossref","first-page":"939","DOI":"10.7326\/0003-4819-109-12-939","article-title":"The Non-Hodgkin Lymphoma Pathologic Classification Project","volume":"109","author":"Simon","year":"1988","journal-title":"Ann Intern Med"},{"issue":"suppl","key":"10.1016\/j.bbmt.2005.07.001_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2141.1975.tb00911.x","article-title":"The histopathology of malignant lymphoma","volume":"31","author":"Lennert","year":"1975","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib17","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(88)90367-4","article-title":"Updated Kiel classification for lymphomas","volume":"1","author":"Stansfeld","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2005.07.001_bib18","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms","volume":"84","author":"Harris","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.07.001_bib19","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1023\/A:1008278706002","article-title":"From the REAL classification to the upcoming WHO scheme","volume":"9","author":"Pileri","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1365-2559.2000.00895.x","article-title":"The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues","volume":"36","author":"Harris","year":"2000","journal-title":"Histopathology"},{"key":"10.1016\/j.bbmt.2005.07.001_bib21","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1056\/NEJM197812282992606","article-title":"Childhood non-Hodgkin\u2019s lymphoma","volume":"299","author":"Murphy","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2005.07.001_bib22","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1097\/00000478-200011000-00003","article-title":"Precursor B-cell lymphoblastic lymphoma","volume":"24","author":"Pei","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib23","first-page":"1295","article-title":"Lymphoblastic lymphoma","volume":"715-748","author":"Knowles","year":"1992","journal-title":"Neoplastic Hemapathol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib24","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1182\/blood-2003-12-4428","article-title":"Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma","volume":"104","author":"Thomas","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.07.001_bib25","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1182\/blood.V72.6.1891.1891","article-title":"Clinical features and outcome in childhood T-cell leukemia-lymphoma according to stage of thymocyte differentiation","volume":"72","author":"Crist","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.07.001_bib26","first-page":"81","article-title":"Immunologic complexity of lymphoblastic lymphoma","volume":"4","author":"Grogan","year":"1986","journal-title":"Diagn Clin Immunol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib27","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1073\/pnas.77.3.1588","article-title":"Discrete stages of human intrathymic differentiation. Analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage","volume":"77","author":"Reinherz","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bbmt.2005.07.001_bib28","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1182\/blood.V61.5.830.830","article-title":"Monoclonal antibody characterization of surface antigens in childhood T-cell lymphoid malignancies","volume":"61","author":"Roper","year":"1983","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.07.001_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0889-8588(05)70200-8","article-title":"Lymphoblastic lymphoma","volume":"15","author":"Thomas","year":"2001","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.bbmt.2005.07.001_bib30","first-page":"365","article-title":"Application of a T-cell receptor antibody \u03b2F1 for immunophenotypic analysis of malignant lymphomas","volume":"132","author":"Ng","year":"1988","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib31","first-page":"434","article-title":"Discordant expression of CD3 and T-cell receptor beta-chain antigens in T-lineage lymphomas","volume":"129","author":"Picker","year":"1987","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib32","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1182\/blood.V68.1.134.134","article-title":"3A1 (CD7) Expression precedes T \u03b2 gene rearrangements in precursor T (lymphoblastic) neoplasms","volume":"68","author":"Pittaluga","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.07.001_bib33","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood.V69.4.1062.1062","article-title":"Development of T3\/T-cell receptor gene expression in human pre-T neoplasms","volume":"69","author":"Pittaluga","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.07.001_bib34","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/ajcp\/79.3.387","article-title":"Lymphoblastic lymphoma with the phenotype of common acute lymphoblastic leukemia","volume":"79","author":"Borowitz","year":"1983","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib35","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0145-2126(87)90183-4","article-title":"Lymphoblastic lymphoma expressions natural killer cell-associated antigens","volume":"11","author":"Sheibani","year":"1987","journal-title":"Leuk Res"},{"key":"10.1016\/j.bbmt.2005.07.001_bib36","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0145-2126(85)90030-X","article-title":"T lymphoblastic lymphoma with LEU7 positive phenotype and unusual clinical course","volume":"9","author":"Swerdlow","year":"1985","journal-title":"Leuk Res"},{"key":"10.1016\/j.bbmt.2005.07.001_bib37","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1182\/blood.V74.7.2508.2508","article-title":"\u03b3\/\u03b4 lineage relationship within a consecutive series of human precursor T-cell neoplasms","volume":"74","author":"de Villartay","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.07.001_bib38","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1182\/blood.V74.7.2501.2501","article-title":"T-lymphoblastic lymphomas expressing nondisulfide-linked form of the T-cell receptor \u03b3\u03b4","volume":"74","author":"Falini","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.07.001_bib39","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/326079a0","article-title":"Differential expression of two distinct T-cell receptors during thymocyte development","volume":"326","author":"Pardoll","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.bbmt.2005.07.001_bib40","first-page":"745","article-title":"A novel translocation t(9;17)(q34)(q23) in aggressive childhood lymphoblastic lymphoma","volume":"2","author":"Kaneko","year":"1988","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2005.07.001_bib41","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00000478-199203000-00003","article-title":"T-cell lymphoblastic lymphoma with eosinophilia associated with subsequent myeloid malignancy","volume":"16","author":"Abruzzo","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib42","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1182\/blood.V85.7.1881.bloodjournal8571881","article-title":"A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia\/malignancy associated with t(8;13)(p11, q11)","volume":"85","author":"Inhorn","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.07.001_bib43","first-page":"1628","article-title":"A new myeloproliferative disorder associated with chromosomal translocation involving 8p11","volume":"9","author":"Macdonald","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2005.07.001_bib44","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1182\/blood.V90.8.3130","article-title":"Abnormalities of chromosome band 8p11 in leukemia","volume":"90","author":"Aguiar","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.07.001_bib45","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s002770050459","article-title":"Graft-versus-host disease following second syngeneic stem SCT for relapse chronic myeloid leukemia","volume":"77","author":"Reiter","year":"1998","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib46","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/ng0198-84","article-title":"FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia\/lymphoma syndrome","volume":"18","author":"Xiao","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.bbmt.2005.07.001_bib47","doi-asserted-by":"crossref","first-page":"6666","DOI":"10.1074\/jbc.M308743200","article-title":"Critical role of STAT5 activation in transformation mediated by ZNF198-FGFR1","volume":"279","author":"Heath","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bbmt.2005.07.001_bib48","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/sj.leu.2401558","article-title":"Therapy-related T-cell lymphoblastic lymphoma with T (11;19)(q23:p13) and MLL gene rearrangement","volume":"13","author":"Thandla","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2005.07.001_bib49","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1200\/JCO.1986.4.11.1628","article-title":"Treatment of lymphoblastic lymphoma in adults","volume":"4","author":"Coleman","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib50","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1200\/JCO.1986.4.1.57","article-title":"Lymphoblastic lymphoma in adults","volume":"4","author":"Slater","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib51","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1182\/blood-2002-01-0110","article-title":"Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia","volume":"99","author":"Hoelzer","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.07.001_bib52","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"International Non-Hodgkin\u2019s Lymphomas Prognostic Factors Project. a predictive model for aggressive Non-Hodgkin\u2019s lymphoma","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2005.07.001_bib53","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1200\/JCO.2001.19.11.2927","article-title":"High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation\/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma","volume":"19","author":"Sweetenham","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib54","first-page":"416","article-title":"Intensive ALL-type therapy without local radiotherapy provides a 90% event free survival for children with T-cell lymphoblastic lymphoma","volume":"95","author":"Reiter","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.07.001_bib55","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1200\/JCO.1995.13.6.1368","article-title":"Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin\u2019s lymphoma","volume":"13","author":"Tubergen","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib56","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","article-title":"Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia","volume":"1","author":"Ferrando","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbmt.2005.07.001_bib57","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1002\/1097-0142(19950401)75:7<1684::AID-CNCR2820750720>3.0.CO;2-2","article-title":"Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia","volume":"75","author":"Arico","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2005.07.001_bib58","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0140-6736(98)04058-6","article-title":"Prognostic value of minimal residual disease in childhood acute lymphoblastic leukemia","volume":"352","author":"van Dongen","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2005.07.001_bib59","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1200\/JCO.1992.10.7.1078","article-title":"Prognosis and treatment of lymphoblastic lymphoma in adults","volume":"10","author":"Morel","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib60","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1023\/A:1008202808144","article-title":"Role of induction chemotherapy and bone marrow transplantation in adult lymphoblastic lymphoma","volume":"9","author":"Bouabdallah","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib61","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/10428199909145953","article-title":"Non-Hodgkin\u2019s lymphoma protocols in the treatment of patients with Burkitt\u2019s lymphoma and lymphoblastic lymphoma","volume":"36","author":"Kaiser","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2005.07.001_bib62","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1182\/blood.V57.1.186.186","article-title":"The chemotherapy of lymphoblastic lymphoma","volume":"57","author":"Voakes","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.07.001_bib63","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/BF00686341","article-title":"Intensive chemotherapy for adult lymphoblastic lymphomas","volume":"29","author":"Liang","year":"1991","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib64","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/10428199409049726","article-title":"Long-term follow-up of a CHOP-based regimen with maintenance therapy and central nervous system prophylaxis in lymphoblastic non-Hodgkin\u2019s lymphoma","volume":"15","author":"Colgan","year":"1994","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2005.07.001_bib65","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s002770100363","article-title":"Adult lymphoblastic lymphoma in Taiwan","volume":"80","author":"Chen","year":"2001","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib66","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1182\/blood.V57.4.679.679","article-title":"Lymphoblastic lymphoma in adults","volume":"52","author":"Coleman","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.07.001_bib67","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1182\/blood.V61.1.92.92","article-title":"Successful therapy of convoluted T-lymphoblastic lymphoma in the adult","volume":"61","author":"Levine","year":"1983","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1016\/j.bbmt.2005.07.001_bib68","first-page":"106","article-title":"Lymphoblastic lymphoma (LBL) and acute lymphoblastic leukemia (ALL) in adults","volume":"4","author":"Santini","year":"1989","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2005.07.001_bib69","first-page":"96","article-title":"Lymphoblastic lymphoma","volume":"17","author":"Picozzi","year":"1990","journal-title":"Semin Oncol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib70","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1182\/blood.V85.8.2025.bloodjournal8582025","article-title":"A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia","volume":"85","author":"Larson","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.07.001_bib71","first-page":"11a","article-title":"Outcome with the hyper-CVAD regimen in lymphoblastic lymphoma","volume":"18","author":"Thomas","year":"1999","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib72","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/10428199609054867","article-title":"Adult lymphoblastic lymphoma","volume":"23","author":"Zinzani","year":"1996","journal-title":"Leuk Lymphoma"},{"issue":"suppl 1","key":"10.1016\/j.bbmt.2005.07.001_bib73","first-page":"754a","article-title":"Acute lymphoblastic leukemia","volume":"86","author":"Daenen","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.07.001_bib74","first-page":"1391a","article-title":"Lymphoblastic lymphoma","volume":"93","author":"Engelhard","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib75","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1200\/JCO.1988.6.1.26","article-title":"Lymphoblastic lymphoma in children","volume":"6","author":"Hvizdala","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib76","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3171\/jns.1999.91.2.0221","article-title":"Rapid infusion of high-doses methotrexate resulting in enhanced penetration into cerebrospinal fluid and intensified tumor response in primary central nervous system lymphomas","volume":"91","author":"Hiraga","year":"1999","journal-title":"J Neurosurg"},{"key":"10.1016\/j.bbmt.2005.07.001_bib77","first-page":"526a","article-title":"Successful treatment of stage III lymphoblastic lymphoma in children without cranial irradiation","volume":"94","author":"Hitzler","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.07.001_bib78","first-page":"332","article-title":"Classification, staging and end results of treatment of childhood non-Hodgkin\u2019s lymphomas","volume":"7","author":"Murphy","year":"1980","journal-title":"Semin Oncol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib79","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1182\/blood.V86.6.2091.bloodjournal8662091","article-title":"The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult lymphoblastic leukemia","volume":"86","author":"Cortes","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.07.001_bib80","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/bjc.1984.201","article-title":"Adjuvant low dose radiation in childhood T cell leukemia\/lymphoma","volume":"50","author":"Mott","year":"1984","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bbmt.2005.07.001_bib81","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1200\/JCO.1993.11.7.1208","article-title":"Cardiac disease following treatment of Hodgkin\u2019s disease in children and adolescents","volume":"11","author":"Hancock","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib82","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJM199603213341201","article-title":"Breast cancer and other second neoplasms after childhood Hodgkin\u2019s disease","volume":"334","author":"Bhatia","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2005.07.001_bib83","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/bjc.1987.91","article-title":"Second malignancies in children treated for non-Hodgkin\u2019s lymphoma and T-cell leukemia with the UKCCSG regimens","volume":"55","author":"Ingram","year":"1987","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bbmt.2005.07.001_bib84","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/1097-0142(19850815)56:4<738::AID-CNCR2820560406>3.0.CO;2-O","article-title":"Effectiveness of a six-drug regimen (APO) without local irradiation for treatment of mediastinal lymphoblastic lymphoma in children","volume":"56","author":"Camitta","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2005.07.001_bib85","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1200\/JCO.1983.1.9.537","article-title":"Long-term results of the APO protocol (vincristine, doxorubicin [Adriamycin], and prednisone) for treatment of mediastinal lymphoblastic lymphoma","volume":"1","author":"Weinstein","year":"1983","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib86","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1182\/blood.V58.4.852.852","article-title":"Histopathology of the thymus of patients with acute lymphoblastic leukemia and lymphoblastic lymphoma in complete remission","volume":"58","author":"Rappaport","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.07.001_bib87","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1182\/blood.V87.8.3143.bloodjournal8783143","article-title":"A randomized phase III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia","volume":"87","author":"Welte","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.07.001_bib88","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1002\/cncr.10552","article-title":"The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma","volume":"94","author":"Dabaja","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2005.07.001_bib89","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1200\/JCO.2000.18.5.995","article-title":"Pharmacokinetics of nelarabine and 9-beta-D-arabinofuranosyl guanine in pediatric and adult patients during a phase I study of nelarabine for the treatment of refractory hematologic malignancies","volume":"18","author":"Kisor","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib90","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/beha.2002.0223","article-title":"Allogeneic haemopoietic stem cell plantation for non-Hodgkin\u2019s lymphoma","volume":"15","author":"Toze","year":"2002","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib91","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1200\/JCO.1994.12.7.1358","article-title":"High-dose therapy and autologous bone marrow transplantation for adult patients with lymphoblastic lymphoma","volume":"12","author":"Sweetenham","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib92","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2141.1989.tb00224.x","article-title":"Bone marrow transplantation for adult poor prognosis lymphoblastic lymphoma in first complete remission","volume":"73","author":"Milpied","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib93","first-page":"33","article-title":"Autologous bone marrow transplantation in 22 adult patients with lymphoblastic lymphoma responsive to conventional dose chemotherapy","volume":"10","author":"Baro","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2005.07.001_bib94","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1200\/JCO.1992.10.4.644","article-title":"Autologous bone marrow transplantation for adult poor-risk lymphoblastic lymphoma in first remission","volume":"10","author":"Verdonck","year":"1992","journal-title":"J Clin Oncol"},{"issue":"suppl 1","key":"10.1016\/j.bbmt.2005.07.001_bib95","first-page":"42","article-title":"Autologous bone marrow transplantation for adult advanced stage lymphoblastic lymphoma in first CR. A study of the NHLCSG","volume":"5","author":"Santini","year":"1991","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2005.07.001_bib96","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/oxfordjournals.annonc.a059214","article-title":"Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt\u2019s lymphomas in adult patients","volume":"6","author":"Jost","year":"1995","journal-title":"Ann Oncol"},{"issue":"suppl 1","key":"10.1016\/j.bbmt.2005.07.001_bib97","first-page":"477a","article-title":"Autologous stem SCT (ASCT) for lymphoblastic lymphoma (LBL) [abstract 2130]","volume":"94","author":"Conde","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.07.001_bib98","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1182\/blood-2002-05-1483","article-title":"A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma","volume":"101","author":"Levine","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.07.001_bib99","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0002-9343(97)89488-0","article-title":"Allogeneic bone marrow transplantation for poor-prognosis lymphoma","volume":"100","author":"van Besien","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.bbmt.2005.07.001_bib100","series-title":"Acute Lymphoblastic Leukemia","first-page":"221","article-title":"Intensified chemotherapy and mediastinal irradiation in adult T-cell acute lymphoblastic leukemia","author":"Hoelzer","year":"1990"},{"key":"10.1016\/j.bbmt.2005.07.001_bib101","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.leu.2401310","article-title":"Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma","volume":"13","author":"Amylon","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2005.07.001_bib102","first-page":"3310","article-title":"Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy","volume":"95","author":"Schrappe","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.07.001_bib103","first-page":"1088","article-title":"Fractioned cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia","volume":"84","author":"Bassan","year":"1999","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2005.07.001_bib104","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1200\/JCO.2003.08.054","article-title":"Syngeneic hematopoietic stem-SCT for non-Hodgkin\u2019s lymphoma","volume":"21","author":"Bierman","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib105","first-page":"2666a","article-title":"2-Amino-9-B-D-arabinosyl-6-methoxy-9H-guanine (GW506U; compound 506U) is highly active in patients with refractory hematological malignancies. [abstract]","volume":"88","author":"Kurtzberg","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.07.001_bib106","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/blood.V77.3.649.649","article-title":"Evidence of graft-vs.-lymphoma effect associated with allogeneic bone marrow transplantation","volume":"77","author":"Jones","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.07.001_bib107","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1182\/blood-2001-11-0107","article-title":"Chemotherapy-resistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation","volume":"100","author":"Robinson","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.07.001_bib108","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/sj.bmt.1700781","article-title":"Management of lymphoma recurrence after allogeneic transplantation","volume":"19","author":"van Besien","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2005.07.001_bib109","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/S0140-6736(05)60328-5","article-title":"Graft-versus-lymphoma effect of donor leucocyte infusion shown by real-time quantitative PCR analysis of t(14;18)","volume":"352","author":"Mandigers","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2005.07.001_bib110","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1182\/blood.V84.4.1050.1050","article-title":"Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin\u2019s lymphoma","volume":"84","author":"Ratanatharathorn","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.07.001_bib111","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1200\/JCO.1992.10.11.1690","article-title":"Autologous versus allogeneic bone marrow transplantation for non-Hodgkin\u2019s lymphoma","volume":"10","author":"Chopra","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib112","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1200\/JCO.2003.05.984","article-title":"The graft-versus-lymphoma effect","volume":"21","author":"Bishop","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2005.07.001_bib113","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"issue":"2 suppl 1","key":"10.1016\/j.bbmt.2005.07.001_bib114","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bbmt.2004.12.005","article-title":"Allogeneic stem cell transplantation in adult ALL","volume":"11","author":"Arnold","year":"2005","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387910500426X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387910500426X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:24:16Z","timestamp":1761056656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108387910500426X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":114,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S108387910500426X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2005.07.001","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemotherapy and Hematopoietic Stem Cell Transplantation for Adult T-Cell Lymphoblastic Lymphoma: Current Status and Controversies","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2005.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}